This HTML5 document contains 139 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.3390/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57065032
rdf:type
wikibase:Item
schema:description
article wetenschappelijk artikel im September 2018 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована у вересні 2018
p:P577
wds:Q57065032-7A324CC2-5BFA-4CFC-AD6E-A20813EFDBF7
wdt:P577
2018-09-29T00:00:00Z
p:P407
wds:Q57065032-1F651113-EE8C-412A-B2DC-3B04282418B2
wdt:P407
wd:Q1860
p:P2860
wds:Q57065032-99A765AA-CDD0-46B2-977A-976C7892EB9D wds:Q57065032-9F5BA9E4-FAE9-4C8D-A731-ED1A6D411572 wds:Q57065032-A8552CE5-2ECD-49D4-8635-8A728E636344 wds:Q57065032-BF954711-4E43-4539-8A87-DF33D525CC9F wds:Q57065032-C309053F-8F72-469C-A3DE-C94C5760A9BD wds:Q57065032-C4DC7E3E-DD0C-4F77-9436-08BF4D3A6E05 wds:Q57065032-74003E80-CACF-4BCE-8707-D42F33DCE44E wds:Q57065032-7A36F34A-A9B2-40DB-AB2F-AB251BA599E8 wds:Q57065032-902CFD85-7DAD-4E88-B4A4-F87563AA01A1 wds:Q57065032-DF6DAE35-8394-4A7C-BA9F-3D31EBC956DC wds:Q57065032-E4C88707-BF32-476B-A513-5F28E4D448AB wds:Q57065032-E95FCA4A-76EB-42BD-9628-1008C8FBC606 wds:Q57065032-E9F46218-08DA-4E82-A5C1-91E1F20B4399 wds:Q57065032-F1132E01-B2A3-4FFD-A986-41F248F6B60A wds:Q57065032-F2D0EE28-DFF1-41E5-B97F-CFB72FDA43FD wds:Q57065032-C72A5683-43DD-439B-ACBF-B804C05FDB62 wds:Q57065032-CC769D5B-CDDC-49A5-8A00-3270CD4A249A wds:Q57065032-CCC1EBC7-F7DB-404E-B7B7-9CB252EF5EE8 wds:Q57065032-CF1BA7C7-3347-4327-99F8-1413F1663454 wds:Q57065032-D2242668-07EB-4567-8CC3-3AB899015DFE wds:Q57065032-D32C592F-0FC5-4565-A0CF-77F4A2A1BE2A wds:Q57065032-10D05CCF-951B-4B5D-9D6A-1D216CD9F81D wds:Q57065032-14394BC0-701B-4740-B89D-352C0E79E757 wds:Q57065032-242B2780-8048-4A38-AC11-157EA4C58A70 wds:Q57065032-2A08C897-5C13-4855-A97E-C7D2DCBDA866 wds:Q57065032-02834227-FA31-4A6D-A185-92B1E49AC446 wds:Q57065032-52EB4011-A778-4D7E-ADCB-9C71A6384793 wds:Q57065032-57406AED-0826-4FFF-9BC3-84FEAF391C16 wds:Q57065032-5D183DFF-E0C6-4C28-844E-247DBC72C3C7 wds:Q57065032-6595722E-C28B-47FC-B6A8-921F5FB767A3 wds:Q57065032-6ED3E9FD-CE8F-4105-84A0-6929E67135C9 wds:Q57065032-72EE5923-2738-4385-AF0E-232143D9B72D wds:Q57065032-31ED702F-0A46-4BE4-8115-63F6196CBD7C wds:Q57065032-325BBA26-5F12-4EA5-8BD0-CAAE98BD15B8 wds:Q57065032-36575616-E6A3-4DF5-BDE7-A751DC455058 wds:Q57065032-3DBC0970-7EB8-4C43-8ACA-549C2969CBED wds:Q57065032-451DC3AA-4D9D-486B-944A-4EDAF6C84974 wds:Q57065032-4E83FA35-0871-419F-B8D5-BC552EFE4679 wds:Q57065032-FF5E7822-F5A3-45E6-9CD0-3B61E1CD0C09
wdt:P2860
wd:Q51080130 wd:Q40789166 wd:Q36544904 wd:Q40276050 wd:Q51204083 wd:Q39454868 wd:Q39564060 wd:Q47867820 wd:Q26751709 wd:Q34664176 wd:Q35499776 wd:Q47191906 wd:Q68555324 wd:Q43698908 wd:Q37437680 wd:Q33903962 wd:Q54959277 wd:Q79387850 wd:Q39855365 wd:Q61626243 wd:Q33438326 wd:Q39740270 wd:Q46748088 wd:Q44594055 wd:Q36381222 wd:Q27336445 wd:Q33334044 wd:Q35136815 wd:Q39190004 wd:Q38763415 wd:Q52981848 wd:Q28137890 wd:Q37765372 wd:Q35842240 wd:Q37717558 wd:Q35999708 wd:Q39270354 wd:Q42002078 wd:Q36640493
p:P2093
wds:Q57065032-6006BF8C-655D-4CA5-B340-358A04F364CD wds:Q57065032-3419867D-A668-45DC-87D5-37F5C4627045 wds:Q57065032-EF5E914A-5042-4291-A572-431E716A819E wds:Q57065032-9B150001-292E-4DFE-8681-09B157D42630 wds:Q57065032-862AAD59-548E-4933-A102-09EEAAFC1802 wds:Q57065032-7FD91752-4D9B-44F5-ABA6-005FAD9BDBCA
wdt:P2093
Hitomi Sudo Yoshikazu Kurosawa Mitsuru Koizumi Gene Kurosawa Tsuneo Saga Aya Sugyo
rdfs:label
Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer
skos:prefLabel
Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer
schema:name
Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer
p:P50
wds:Q57065032-D94FB69E-2C2F-4CE5-BE32-9F36536D9830 wds:Q57065032-8308169A-65DD-46DF-BA97-BE8E8D5828F8 wds:Q57065032-71744F30-1BEC-4C3C-A184-DECBE9B514DF
wdt:P50
wd:Q87661752 wd:Q56650574 wd:Q39052260
p:P1476
wds:Q57065032-F24D5D02-E8AE-4A67-A9DF-2CF5A4A7C3D7
wdt:P1476
Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with 90Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer
p:P31
wds:Q57065032-07E84D0E-98AA-40B0-9044-085DA1565C53
wdt:P31
wd:Q13442814
p:P921
wds:Q57065032-9268F141-1192-43CE-83B9-26CF632F470E wds:Q57065032-F4429D94-4DB7-4D87-B9C7-2B27150D103C wds:Q57065032-028371FC-B9C2-4AAE-861A-70113A0C11D9
wdt:P921
wd:Q64148587 wd:Q212961 wd:Q422248
p:P698
wds:Q57065032-25133B2A-9715-44A7-A7D2-0BB87D9D4D09
wdtn:P698
n8:30274301
wdt:P698
30274301
p:P1433
wds:Q57065032-74C494BB-19C6-4252-908D-5C7D5D30548B
wdt:P1433
wd:Q3153277
p:P433
wds:Q57065032-1D6E520A-636A-4DBF-B338-7CEC69284AFE
p:P478
wds:Q57065032-FB005C86-D8A8-480A-B3D5-6392178862A4
wdt:P433
10
wdt:P478
19
p:P356
wds:Q57065032-425EDA9E-831E-490C-8CCF-CF26D06B7529
wdtn:P356
n12:IJMS19102979
wdt:P356
10.3390/IJMS19102979
p:P275
wds:Q57065032-07885649-b6ef-450d-8525-bf3f56aae8cd
p:P6216
wds:Q57065032-25bcd8eb-a0ec-4422-86aa-3d0bba554586
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P932
wds:Q57065032-DA05F9A4-1F97-45EC-B3B4-31A26183C09E
wdt:P932
6213240